Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study

M. N. Ghazanfar, J. G. Holm, S. F. Thomsen

14 Citationer (Scopus)

Originalsprog	Engelsk
Bogserie	Journal of the European Academy of Dermatology and Venereology. Supplement
Vol/bind	32
Udgave nummer	10
Sider (fra-til)	1761-1767
ISSN	0926-9959
DOI	https://doi.org/10.1111/jdv.15045
Status	Udgivet - okt. 2018

Adgang til dokumentet

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{d5870814279b49ca97e03bb6e47ae936,

title = "Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study",

author = "Ghazanfar, {M. N.} and Holm, {J. G.} and Thomsen, {S. F.}",

year = "2018",

month = oct,

doi = "10.1111/jdv.15045",

language = "English",

volume = "32",

pages = "1761--1767",

journal = "Journal of the European Academy of Dermatology and Venereology. Supplement",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes

T2 - a prospective study

AU - Ghazanfar, M. N.

AU - Holm, J. G.

AU - Thomsen, S. F.

PY - 2018/10

Y1 - 2018/10

U2 - 10.1111/jdv.15045

DO - 10.1111/jdv.15045

M3 - Journal article

C2 - 29729103

SN - 0926-9959

VL - 32

SP - 1761

EP - 1767

JO - Journal of the European Academy of Dermatology and Venereology. Supplement

JF - Journal of the European Academy of Dermatology and Venereology. Supplement

IS - 10

ER -